The Metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: The Guangzhou Biobank Cohort Study-CVD

Clinical Endocrinology

Volumn 73, Issue 2, 2010, Pages 181-188

  Xu, Lin ^a,b   Jiang, Chao Qiang ^b   Lam, Tai Hing ^a   Lin, Jie Ming ^b   Yue, Xiao Jun ^b   Cheng, Kar Keung ^c   Liu, Bin ^b   Jin, Ya Li ^b   Zhang, Wei Sen ^b   Thomas, G Neil ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Guangzhou No 12 Hospital   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RISK; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS;

EID: 77954868505     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03760.x     Document Type: Article

References (32)

1. Eckel, R.H., Grundy, S.M. Zimmet, P.Z. (2005) The metabolic syndrome. Lancet 365, 1415 1428.
2. Gale, E.A. (2005) The myth of the metabolic syndrome. Diabetologia 48, 1679 1683.
3. Kahn, R., Buse, J., Ferrannini, E. et al. (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289 2304. (Pubitemid 41242486)
4. Reaven, G.M. (2005) The metabolic syndrome: requiescat in pace. Clinical Chemistry 51, 931 938.
5. Alberti, K.G., Zimmet, P. Shaw, J. (2005) The metabolic syndrome - a new worldwide definition. Lancet 366, 1059 1062. (Pubitemid 41338752)
6. Alberti, K.G. Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 15, 539 553.
7. Lao, X.Q., Thomas, G.N., Jiang, C.Q. et al. (2007) c-Reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study. Atherosclerosis 194, 483 489.
8. Lao, X.Q., Thomas, G.N., Jiang, C.Q. et al. (2006) Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study. Journal of Endocrinological Investigation 29, 989 996.
9. Ferreira, I., Boreham, C.A., Twisk, J.W. et al. (2007) Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project. Journal of Hypertension 25, 1009 1020.
10. Bertoni, A.G., Wong, N.D., Shea, S. et al. (2007) Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 30, 2951 2956.
11. Ahluwalia, N., Drouet, L., Ruidavets, J.B. et al. (2006) Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 186, 345 353.
12. Taniguchi, A., Fukushima, M., Kuroe, A. et al. (2007) Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients. Metabolism 56, 1099 1103.
13. Bruno, G., Merletti, F., Biggeri, A. et al. (2004) Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27, 2689 2694.
14. Jiang, C.Q., Thomas, G.N., Lam, T.H. et al. (2006) Cohort profile: The Guangzhou Biobank Cohort Study, a Guangzhou-Hong Kong-Birmingham collaboration. International Journal of Epidemiology 35, 844 852.
15. Jiang, C.Q., Lam, T.H., Lin, J.M. et al. (2009) An overview of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort (GBCS-CVD): a platform for multidisciplinary collaboration. Journal of Human Hypertension July 10; [Epub ahead of print].
16. Deng, H.B., Macfarlane, D.J., Thomas, G.N. et al. (2008) Reliability and validity of the IPAQ-Chinese: the Guangzhou Biobank Cohort study. Medicine and Science in Sports and Exercise 40, 303 307.
17. Jiang, C.Q., Lao, X.Q., Yin, P. et al. (2009) Smoking, smoking cessation and aortic arch calcification in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 202, 529 534.
18. Thomas, G.N., Young, R.P., Tomlinson, B. et al. (1999) A sibling-pair analysis of fasting lipids and anthropometric measurements and their relationship to hypertension. Clinical and Experimental Hypertension [A] 21, 1161 1176.
19. Rutter, M.K., Wilson, P.W., Sullivan, L.M. et al. (2008) Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 117, 1003 1009.
20. Grundy, S.M., Cleeman, J.I., Daniels, S.R. et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart AssociationNational Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735 2752.
21. Simon, A., Gariepy, J., Chironi, G. et al. (2002) Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. Journal of Hypertension 20, 159 169.
22. Yamashina, A., Tomiyama, H., Arai, T. et al. (2003) Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertension Research 26, 615 622.
23. Murabito, J.M., Evans, J.C., Larson, M.G. et al. (2003) The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Archives of Internal Medicine 163, 1939 1942.
24. Holewijn, S., den Heijer, M., Swinkels, D.W. et al. (2009) The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab 94, 2893 2899.
25. McNeill, A.M., Rosamond, W.D., Girman, C.J. et al. (2004) Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). American Journal of Cardiology 94, 1249 1254.
26. Lin, W.Y., Lai, M.M., Li, C.I. et al. (2009) In addition to insulin resistance and obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese - a population-based study (Taichung Community Health Study, TCHS). Journal of Atherosclerosis and Thrombosis 16, 105 112.
27. Rutter, M.K., Meigs, J.B., Sullivan, L.M. et al. (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54, 3252 3257.
28. Wikstrom, J., Hansen, T., Johansson, L. et al. (2008) Ankle brachial index <0.9 underestimates the prevalence of peripheral artery occlusive disease assessed with whole-body magnetic resonance angiography in the elderly. Acta Radiologica 49, 143 149.
29. Frohlich, M., Imhof, A., Berg, G. et al. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23, 1835 1839.
30. Ridker, P.M., Buring, J.E., Cook, N.R. et al. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391 397.
31. Gannage-Yared, M.H., Khalife, S., Semaan, M. et al. (2006) Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. European Journal of Endocrinology 155, 167 176.
32. Ntyintyane, L., Panz, V., Raal, F.J. et al. (2009) Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease. Metabolic Syndrome and Related Disorders 7, 243 248.